why choose us

First received: June 11, 2024

Clinical Trial: Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Meningioma

Study Type: OBSERVATIONAL


Official Title: Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

Brief Summary: The aim of this study was to compare a semi-automatic segmentation method with manual reference segmentation to determine an overall tumor volume on post-therapy scintigraphy at D1 in patients treated with 177Lu-DOTATATE for meningioma or neuroendocrine tumor for dosimetric calculation.

Read more